Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022)
Cartesian Therapeutics (RNAC) reported Change in Taxes of -$321000.0 for Q3 2022, down 102.03% year-over-year from $15.8 million in Q3 2021, and down 32200.0% quarter-over-quarter from $1000.0 in Q2 2022.
Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022) Analysis & Trends
Cartesian Therapeutics (RNAC) has 2 years of Change in Taxes data on file, last reported at -$321000.0 in Q3 2022.
- Change in Taxes for Q3 2022 came in at -$321000.0, down 102.03% year-over-year; the trailing twelve-month figure through Jun 2023 was -$321000.0 (down 200.0% YoY), and the FY2022 annual result was -$601000.0, down 200.0% from the prior year.
- Change in Taxes retreated to -$321000.0 in Q3 2022 per RNAC's latest filing, from $1000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $15.8 million in Q3 2021 and troughed at -$15.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -321,000.00 |
| Sep 30, 2022 | -321,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -281,000.00 |
| Mar 31, 2022 | -281,000.00 |
| Dec 31, 2021 | -15.23 Mn |
| Dec 31, 2021 | -15.23 Mn |
| Sep 30, 2021 | 15.83 Mn |
| Sep 30, 2021 | 15.83 Mn |